Amyloid Neuropathies With Dr. Marcus Vinicius R. Pinto
27 min
Amyloid neuropathies are important causes of progressive neuropathy and are increasingly treatable when recognized earlier. In this episode, Dr. Marcus Pinto reviews the major types of amyloid neuropathy, key diagnostic red flags, and the evolving treatment options for AL and hereditary ATTR amyloidosis. Learn how timely diagnosis can help prevent disease progression and improve patient outcomes. In this episode, Gordon Smith, MD, FAAN, speaks with Marcus V. Pinto, MD, MS, author of the article "Amyloid Neuropathies" in the Continuum® October 2026 Peripheral Nerve and Motor Neuron Disorders issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Pinto is an assistant professor of neurology and medical director of the Nerve Pathology Laboratory at Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: Amyloid Neuropathies Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @GordonSmithMD Guest: @MarcusVPinto Full episode transcript available here Dr. Smith: One of the wonderful things about being a neurologist these days is the unbelievable therapeutic development, particularly for diseases that have been historically devastating for patients. I suspect many of you, like me, have found amyloidosis a sometimes confusing topic, but given the exciting therapeutic development for amyloid, it's a diagnosis that you really can't afford to miss if you're seeing patients with neuropathy. If you're interested in seeing order out of chaos and learning about amy...